Medicare IVF Data Uptick Encouraging; Maintaining FVE for Monash IVF Group
We maintain our AUD 2.00 fair value estimate for no-moat-rated Monash IVF Group following the release of Medicare IVF volume data for February 2017. Total fresh and frozen cycle volumes, on a combined basis, increased by 4% on a previous corresponding period, or pcp. This comprised an 8% rise in frozen embryo transfer cycles and a more modest 1% gain in fresh IVF cycle volumes compared with the pcp. On a 12-month rolling basis, fresh and frozen cycle volumes combined increased by 1%.Queensland ...
Healthbridge Enterprises is engaged in the provision of medical services in the area of human reproduction and human pathology.
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.